Cryopreservation of cancer-initiating cells derived from glioblastoma

Frontiers in Bioscience - Scholar

Volumn 3 S, Issue 2, 2011, Pages 698-708

  Foong, Charlene Shu Fen ^a,b   Ng Lee, Felicia Soo ^c   Phong, Mark ^c   Toh, Tan Boon ^b   Chong, Yuk Kien ^a,b   Tucker Kellogg, Greg ^c,d   Campbell, Robert Morris ^c   Ang, Beng Ti ^a,b,e,f   Tang, Carol ^e,f  

^a AGENCY FOR SCIENCE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c Eli Lilly Singapore Pte Ltd   (Singapore)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^e DUKE NUS MEDICAL SCHOOL   (Singapore)

^f NATIONAL NEUROSCIENCE INSTITUTE   (Singapore)

Author keywords

Brain Tumor Stem Cells; Glioblastoma Multiforme; Review; Vitrification

Indexed keywords

ADENOMA; ARTICLE; CANCER STEM CELL; CELL RENEWAL; CELL STRUCTURE; CELL VIABILITY; CHROMOSOME 10; CRYOPRESERVATION; DRUG SCREENING; EMBRYONIC STEM CELL; FREEZING; GENE AMPLIFICATION; GENE EXPRESSION; GLIOBLASTOMA; HUMAN; KARYOTYPING; NONHUMAN; QUANTITATIVE ANALYSIS; SERUM; TUMOR CLASSIFICATION; TUMOR XENOGRAFT; VITRIFICATION; ANIMAL; BRAIN TUMOR; DRUG EFFECT; ISOLATION AND PURIFICATION; METHODOLOGY; MOUSE; PATHOLOGY; REVIEW;

MUS;

ANTINEOPLASTIC AGENT;

ANIMALS; ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; CRYOPRESERVATION; DRUG SCREENING ASSAYS, ANTITUMOR; GLIOBLASTOMA; HUMANS; MICE; NEOPLASTIC STEM CELLS;

EID: 79955954521     PISSN: 19450516     EISSN: 19450524     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. M. Al-Hajj, M. S. Wicha, A. Benito-Hernandez, S. J. Morrison and M. F. Clarke: Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA, 100(7), 3983-8 (2003)
2. D. Bonnet and J. E. Dick: Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med, 3(7), 730-7 (1997)
3. R. Galli, E. Binda, U. Orfanelli, B. Cipelletti, A. Gritti, S. De Vitis, R. Fiocco, C. Foroni, F. Dimeco and A. Vescovi: Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res, 64(19), 7011-21 (2004)
4. C. A. O'Brien, A. Pollett, S. Gallinger and J. E. Dick: A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature, 445(7123), 106-10 (2007)
5. L. Ricci-Vitiani, D. G. Lombardi, E. Pilozzi, M. Biffoni, M. Todaro, C. Peschle and R. De Maria: Identification and expansion of human colon-cancer-initiating cells. Nature, 445(7123), 111-5 (2007)
6. S. K. Singh, I. D. Clarke, M. Terasaki, V. E. Bonn, C. Hawkins, J. Squire and P. B. Dirks: Identification of a cancer stem cell in human brain tumors. Cancer Res, 63(18), 5821-8 (2003)
7. X. Yuan, J. Curtin, Y. Xiong, G. Liu, S. Waschsmann- Hogiu, D. L. Farkas, K. L. Black and J. S. Yu: Isolation of cancer stem cells from adult glioblastoma multiforme. Oncogene, 23(58), 9392-400 (2004)
8. S. Alcantara Llaguno, J. Chen, C. H. Kwon, E. L. Jackson, Y. Li, D. K. Burns, A. Alvarez-Buylla and L. F. Parada: Malignant astrocytomas originate from neural stem/progenitor cells in a somatic tumor suppressor mouse model. Cancer Cell, 15(1), 45-56 (2009)
9. H. Zheng, H. Ying, H. Yan, A. C. Kimmelman, D. J. Hiller, A. J. Chen, S. R. Perry, G. Tonon, G. C. Chu, Z. Ding, J. M. Stommel, K. L. Dunn, R. Wiedemeyer, M. J. You, C. Brennan, Y. A. Wang, K. L. Ligon, W. H. Wong, L. Chin and R. A. DePinho: p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation. Nature, 455(7216), 1129-33 (2008)
10. S. K. Singh, C. Hawkins, I. D. Clarke, J. A. Squire, J. Bayani, T. Hide, R. M. Henkelman, M. D. Cusimano and P. B. Dirks: Identification of human brain tumour initiating cells. Nature, 432(7015), 396-401 (2004)
11. M. J. Son, K. Woolard, D. H. Nam, J. Lee and H. A. Fine: SSEA-1 is an enrichment marker for tumor-initiating cells in human glioblastoma. Cell Stem Cell, 4, 440-452 (2009)
12. E. Quintana, M. Shackleton, M. S. Sabel, D. R. Fullen, T. M. Johnson and S. J. Morrison: Efficient tumour formation by single human melanoma cells. Nature, 456(7222), 593-8 (2008)
13. J. Lee, S. Kotliarova, Y. Kotliarov, A. Li, Q. Su, N. M. Donin, S. Pastorino, B. W. Purow, N. Christopher, W. Zhang, J. K. Park and H. A. Fine: Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell, 9(5), 391-403 (2006)
14. R. G. Verhaak, K. A. Hoadley, E. Purdom, V. Wang, Y. Qi, M. D. Wilkerson, C. R. Miller, L. Ding, T. Golub, J. P. Mesirov, G. Alexe, M. Lawrence, M. O'Kelly, P. Tamayo, B. A. Weir, S. Gabriel, W. Winckler, S. Gupta, L. Jakkula, H. S. Feiler, J. G. Hodgson, C. D. James, J. N. Sarkaria, C. Brennan, A. Kahn, P. T. Spellman, R. K. Wilson, T. P. Speed, J. W. Gray, M. Meyerson, G. Getz, C. M. Perou and D. N. Hayes: Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell, 17(1), 98-110 (2010)
15. Y. K. Chong, T. B. Toh, N. Zaiden, A. Poonepalli, S. H. Leong, C. E. Ong, Y. Yu, P. B. Tan, S. J. See, W. H. Ng, I. Ng, M. P. Hande, O. L. Kon, B. T. Ang and C. Tang: Cryopreservation of neurospheres derived from human glioblastoma multiforme. Stem Cells, 27(1), 29-39 (2009)
16. S. M. Pollard, K. Yoshikawa, I. D. Clarke, D. Danovi, S. Stricker, R. Russell, J. Bayani, R. Head, M. Lee, M. Bernstein, J. A. Squire, A. Smith and P. Dirks: Glioma stem cell lines expanded in adherent culture have tumorspecific phenotypes and are suitable for chemical and genetic screens. Cell Stem Cell, 4(6), 568-80 (2009)
17. C. Lottaz, D. Beier, K. Meyer, P. Kumar, A. Hermann, J. Schwarz, M. Junker, P. J. Oefner, U. Bogdahn, J. Wischhusen, R. Spang, A. Storch and C. P. Beier: Transcriptional profiles of CD133+ and CD133- glioblastoma-derived cancer stem cell lines suggest different cells of origin. Cancer Res, 70(5), 2030- 40 (2010)
18. S. Jessberger, G. D. Clemenson, Jr. and F. H. Gage: Spontaneous fusion and nonclonal growth of adult neural stem cells. Stem Cells, 25(4), 871-4 (2007)
19. B. A. Reynolds and R. L. Rietze: Neural stem cells and neurospheres-re-evaluating the relationship. Nat Methods, 2(5), 333-6 (2005)
20. I. Singec, R. Knoth, R. P. Meyer, J. Maciaczyk, B. Volk, G. Nikkhah, M. Frotscher and E. Y. Snyder: Defining the actual sensitivity and specificity of the neurosphere assay in stem cell biology. Nat Methods, 3(10), 801-6 (2006)
21. S. Y. Ha, B. C. Jee, C. S. Suh, H. S. Kim, S. K. Oh, S. H. Kim and S. Y. Moon: Cryopreservation of human embryonic stem cells without the use of a programmable freezer. Hum Reprod, 20(7), 1779-85 (2005)
22. C. R. Hancock, J. P. Wetherington, N. A. Lambert and B. G. Condie: Neuronal differentiation of cryopreserved neural progenitor cells derived from mouse embryonic stem cells. Biochem Biophys Res Commun, 271(2), 418-21 (2000)
23. J. Milosevic, A. Storch and J. Schwarz: Cryopreservation does not affect proliferation and multipotency of murine neural precursor cells. Stem Cells, 23(5), 681-8 (2005)
24. B. E. Reubinoff, M. F. Pera, G. Vajta and A. O. Trounson: Effective cryopreservation of human embryonic stem cells by the open pulled straw vitrification method. Hum Reprod, 16(10), 2187-94 (2001)
25. Tan F.C. Lee K.H. Gouk S.S. Magalhaes R. Poonepalli A. Hande M.P. Dawe G.S. Kuleshova L.L. Optimization of cryopreservation of stem cells cultured as neurospheres: Comparison between vitrification, slowcooling and rapid cooling freezing protocols Cryo Letters 2007 28 6 445-460.
26. F. C. Tan, K. H. Lee, S. S. Gouk, R. Magalhaes, A. Poonepalli, M. P. Hande, G. S. Dawe and L. L. Kuleshova: Optimization of cryopreservation of stem cells cultured as neurospheres: comparison between vitrification, slowcooling and rapid cooling freezing protocols. Cryo Letters, 28(6), 445-60 (2007) 26. W. F. Rall and G. M. Fahy: Ice-free cryopreservation of mouse embryos at -196 degrees C by vitrification. Nature, 313(6003), 573-5 (1985)
27. W. F. Rall, M. J. Wood, C. Kirby and D. G. Whittingham: Development of mouse embryos cryopreserved by vitrification. J Reprod Fertil, 80(2), 499-504 (1987)
28. Y. Wu, H. Yu, S. Chang, R. Magalhaes and L. L. Kuleshova: Vitreous cryopreservation of cell-biomaterial constructs involving encapsulated hepatocytes. Tissue Eng, 13(3), 649-58 (2007)
29. A. L. Vescovi, R. Galli and B. A. Reynolds: Brain tumour stem cells. Nat Rev Cancer, 6(6), 425-36 (2006)
30. X. G. Mao, G. Guo, P. Wang, X. Zhang, X. Y. Xue, W. Zhang, Z. Fei, X. F. Jiang and M. Yan: Maintenance of critical properties of brain tumor stem-like cells after cryopreservation. Cell Mol Neurobiol, 30(5), 775-86 (2010)
31. S. G. Piccirillo, B. A. Reynolds, N. Zanetti, G. Lamorte, E. Binda, G. Broggi, H. Brem, A. Olivi, F. Dimeco and A. L. Vescovi: Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumourinitiating cells. Nature, 444(7120), 761-5 (2006)
32. V. Clement, P. Sanchez, N. de Tribolet, I. Radovanovic and A. Ruiz i Altaba: HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell selfrenewal, and tumorigenicity. Curr Biol, 17(2), 165-72 (2007)
33. Diamandis P. Wildenhain J. Clarke I.D. Sacher A.G. Graham J. Bellows D.S. Ling E.K. Ward R.J. Jamieson L.G. Tyers M. Dirks P.B. Chemical genetics reveals a complex functional ground state of neural stem cells Nat Chem Biol 2007 3 5 268-273.
34. P. Diamandis, J. Wildenhain, I. D. Clarke, A. G. Sacher, J. Graham, D. S. Bellows, E. K. Ling, R. J. Ward, L. G. Jamieson, M. Tyers and P. B. Dirks: Chemical genetics reveals a complex functional ground state of neural stem cells. Nat Chem Biol, 3(5), 268-73 (2007) 34. A. Eramo, L. Ricci-Vitiani, A. Zeuner, R. Pallini, F. Lotti, G. Sette, E. Pilozzi, L. M. Larocca, C. Peschle and R. De Maria: Chemotherapy resistance of glioblastoma stem cells. Cell Death Differ, 13(7), 1238-41 (2006)
35. E. E. Bar, A. Chaudhry, A. Lin, X. Fan, K. Schreck, W. Matsui, S. Piccirillo, A. L. Vescovi, F. DiMeco, A. Olivi and C. G. Eberhart: Cyclopamine-mediated hedgehog pathway inhibition depletes stem-like cancer cells in glioblastoma. Stem Cells, 25(10), 2524-33 (2007)
36. A. M. Bleau, D. Hambardzumyan, T. Ozawa, E. I. Fomchenko, J. T. Huse, C. W. Brennan and E. C. Holland: PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells. Cell Stem Cell, 4(3), 226-35 (2009)
37. G. V. Glinsky: "Stemness" genomics law governs clinical behavior of human cancer: implications for decision making in disease management. J Clin Oncol, 26(17), 2846-53 (2008)
38. A. Murat, E. Migliavacca, T. Gorlia, W. L. Lambiv, T. Shay, M. F. Hamou, N. de Tribolet, L. Regli, W. Wick, M. C. Kouwenhoven, J. A. Hainfellner, F. L. Heppner, P. Y. Dietrich, Y. Zimmer, J. G. Cairncross, R. C. Janzer, E. Domany, M. Delorenzi, R. Stupp and M. E. Hegi: Stem cell-related "self- renewal" signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma. J Clin Oncol, 26(18), 3015-24 (2008)
39. H. D. Hemmati, I. Nakano, J. A. Lazareff, M. Masterman-Smith, D. H. Geschwind, M. Bronner-Fraser and H. I. Kornblum: Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci USA, 100(25), 15178-83 (2003)
40. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature, 455(7216), 1061-8 (2008)
41. F. Pistollato, S. Abbadi, E. Rampazzo, L. Persano, A. Della Puppa, C. Frasson, E. Sarto, R. Scienza, D. D'Avella and G. Basso: Intratumoral hypoxic gradient drives stem cells distribution and MGMT expression in glioblastoma. Stem Cells, 28(5), 851-62 (2010)
42. A. Li, J. Walling, Y. Kotliarov, A. Center, M. E. Steed, S. J. Ahn, M. Rosenblum, T. Mikkelsen, J. C. Zenklusen and H. A. Fine: Genomic changes and gene expression profiles reveal that established glioma cell lines are poorly representative of primary human gliomas. Mol Cancer Res, 6(1), 21-30 (2008)
43. B. A. Reynolds and A. L. Vescovi: Brain cancer stem cells: Think twice before going flat. Cell Stem Cell, 5(5), 466-7; author reply 468-9 (2009)
44. M. S. Chen, W. A. Woodward, F. Behbod, S. Peddibhotla, M. P. Alfaro, T. A. Buchholz and J. M. Rosen: Wnt/beta-catenin mediates radiation resistance of Sca1+ progenitors in an immortalized mammary gland cell line. J Cell Sci, 120(Pt 3), 468-77 (2007)
45. N. A. Dallas, L. Xia, F. Fan, M. J. Gray, P. Gaur, G. van Buren, 2nd, S. Samuel, M. P. Kim, S. J. Lim and L. M. Ellis: Chemoresistant colorectal cancer cells, the cancer stem cell phenotype, and increased sensitivity to insulinlike growth factor-I receptor inhibition. Cancer Res, 69(5), 1951-7 (2009)
46. S. H. Lang, R. M. Sharrard, M. Stark, J. M. Villette and N. J. Maitland: Prostate epithelial cell lines form spheroids with evidence of glandular differentiation in threedimensional Matrigel cultures. Br J Cancer, 85(4), 590-9 (2001)
47. D. A. Lawson, L. Xin, R. U. Lukacs, D. Cheng and O. N. Witte: Isolation and functional characterization of murine prostate stem cells. Proc Natl Acad Sci USA, 104(1), 181-6 (2007)
48. C. Stuelten, S. Mertins, J. Busch, M. Gowens, D. Scudiero, M. Burkett, K. Hite, M. Alley, M. Hollingshead, R. Shoemaker and J. Niederhuber: Complex Display of Putative Tumor Stem Cell Markers in the NCI60 Tumor Cell Line Panel. Stem Cells (2010)
49. Woodward W.A. Chen M.S. Behbod F. Alfaro M.P. Buchholz T.A. Rosen J.M. WNT/beta-catenin mediates radiation resistance of mouse mammary progenitor cells Proc Natl Acad Sci USA 2007 104 2 618-623.
50. W. A. Woodward, M. S. Chen, F. Behbod, M. P. Alfaro, T. A. Buchholz and J. M. Rosen: WNT/beta-catenin mediates radiation resistance of mouse mammary progenitor cells. Proc Natl Acad Sci USA, 104(2), 618-23 (2007) 50. D. Beier, P. Hau, M. Proescholdt, A. Lohmeier, J. Wischhusen, P. J. Oefner, L. Aigner, A. Brawanski, U. Bogdahn and C. P. Beier: CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res, 67(9), 4010-5 (2007)
51. K. M. Joo, S. Y. Kim, X. Jin, S. Y. Song, D. S. Kong, J. I. Lee, J. W. Jeon, M. H. Kim, B. G. Kang, Y. Jung, J. Jin, S. C. Hong, W. Y. Park, D. S. Lee, H. Kim and D. H. Nam: Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas. Lab Invest, 88(8), 808-15 (2008)
52. J. Wang, P. O. Sakariassen, O. Tsinkalovsky, H. Immervoll, S. O. Boe, A. Svendsen, L. Prestegarden, G. Rosland, F. Thorsen, L. Stuhr, A. Molven, R. Bjerkvig and P. O. Enger: CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells. Int J Cancer, 122(4), 761-8 (2008)
53. H. S. Gunther, N. O. Schmidt, H. S. Phillips, D. Kemming, S. Kharbanda, R. Soriano, Z. Modrusan, H. Meissner, M. Westphal and K. Lamszus: Glioblastomaderived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria. Oncogene, 27(20), 2897-909 (2008)
54. X. L. Xu and A. M. Kapoun: Heterogeneous activation of the TGFbeta pathway in glioblastomas identified by gene expression-based classification using TGFbetaresponsive genes. J Transl Med, 7, 12 (2009)
55. H. Zheng, H. Ying, R. Wiedemeyer, H. Yan, S. N. Quayle, E. V. Ivanova, J. H. Paik, H. Zhang, Y. Xiao, S. R. Perry, J. Hu, A. Vinjamoori, B. Gan, E. Sahin, M. G. Chheda, C. Brennan, Y. A. Wang, W. C. Hahn, L. Chin and R. A. DePinho: PLAGL2 regulates Wnt signaling to impede differentiation in neural stem cells and gliomas. Cancer Cell, 17(5), 497-509 (2010)
56. R. C. Castellino and D. L. Durden: Mechanisms of disease: The PI3K-Akt-PTEN signaling node-an intercept point for the control of angiogenesis in brain tumors. Nat Clin Pract Neurol, 3(12), 682-93 (2007)
57. Hambardzumyan D. Squatrito M. Carbajal E. Holland E.C. Glioma formation, cancer stem cells, and Akt signaling Stem Cell Rev 2008 4 3 203-210.
58. D. Hambardzumyan, M. Squatrito, E. Carbajal and E. C. Holland: Glioma formation, cancer stem cells, and Akt signaling. Stem Cell Rev, 4(3), 203-10 (2008) 58. C. B. Knobbe, A. Trampe-Kieslich and G. Reifenberger: Genetic alteration and expression of the phosphoinositol-3-kinase/Akt pathway genes PIK3CA and PIKE in human glioblastomas. Neuropathol Appl Neurobiol, 31(5), 486-90 (2005)
59. C. E. Eyler, W. C. Foo, K. M. LaFiura, R. E. McLendon, A. B. Hjelmeland and J. N. Rich: Brain cancer stem cells display preferential sensitivity to Akt inhibition. Stem Cells, 26(12), 3027-36 (2008)
60. R. S. Carroll, J. Zhang, K. Dashner, M. Sar and P. M. Black: Steroid hormone receptors in astrocytic neoplasms. Neurosurgery, 37(3), 496-503; discussion 503-4 (1995)
61. G. R. Nakayama, M. C. Caton, M. P. Nova and Z. Parandoosh: Assessment of the Alamar Blue assay for cellular growth and viability in vitro. J Immunol Methods, 204(2), 205-8 (1997)